MedPath

The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Dietary Supplement: Species of Lactobacillus
Dietary Supplement: lactose
Registration Number
NCT02448940
Lead Sponsor
Urmia University of Medical Sciences
Brief Summary

The investigators aimed to study the effect of supplementation with species of Lactobacillus on anthropometric measurements, body composition, appetite and serum lipid profile in overweight and obese adults

Detailed Description

The Objective of This Study was Evaluating the Effect of supplementation with Species of Lactobacillus on anthropometric measurements include weight, waist and hip circumference , body composition include body fat and muscle percent, appetite measured by visual analogues scale and serum lipid profile in overweight and obese adults.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Age 18-65 years
  • BMI more than 25 Kg/m2
Exclusion Criteria
  • taking drugs that could affect weight change, including anti-diabetic drugs, lipid lowering drugs
  • endocrine,cardiovascular, thyroid, or chronic liver disease.
  • had received surgery to reduce weight
  • taking probiotics or antibiotics within one month
  • Pregnancy or lactation or menopause
  • A history of cancer
  • Heart disease - cardiovascular, pulmonary, renal and diabetes
  • A history of autoimmune disease
  • Taking certain medications such as blood pressure control, statins, insulin sensitivity enhancers
  • weight change over five percent within three months
  • change in activity or diet habit

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Species of LactobacillusSpecies of Lactobacillus2 capsule/day of Lactofem Containing Species of Lactobacillus
lactoselactose2 capsule/day Containing lactose
Primary Outcome Measures
NameTimeMethod
weight changeChange from Baseline in body weight at 12 weeks
Secondary Outcome Measures
NameTimeMethod
defecationBaseline,4 weeks, 8 weeks, 12 weeks

Bristol stool scale (BBS)

blood pressureBaseline,12 weeks

include systolic and diastolic blood pressure

Anthropometric Measurement BMIBaseline,4 weeks, 8 weeks, 12 weeks

Body Mass Index (BMI) kg/m2

Anthropometric Measurement WCBaseline,12 weeks

waist circumference (WC) measures by "cm"

Anthropometric Measurement HCBaseline,12 weeks

hip circumference (HC) measures by "cm"

AppetiteBaseline,4 weeks, 8 weeks, 12 weeks

numeric analogue Scale (NAS) mm

Anthropometric Measurement WHRBaseline,12 weeks

waist to hip ratio (WHR)

mid arm circumference MeasurementBaseline,12 weeks
Serum Lipid ProfileBaseline,12 weeks
skinfold thicknessBaseline,12 weeks

triceps, biceps, supra iliac and subscapular skinfold

body fat percentBaseline,12 weeks

Trial Locations

Locations (1)

sardrood Clinic

🇮🇷

Tabriz, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath